Baltimore, Maryland 21201


Purpose:

The purpose of the study is to determine the safety and effectiveness of the Jarvik 2000 Heart as a bridge to heart transplantation in end-stage heart failure patients who are approved heart transplant candidates.


Study summary:

The Jarvik 2000 Heart is a silent compact axial flow impeller pump of 1 inch diameter, weighing 90g with a displacement volume of 25ml. The pump is implanted into the apex of the left ventricle by left thoracotomy, or by mid-sternotomy, or by the subcostal approach. A vascular graft offloads to either the descending thoracic aorta, the ascending thoracic aorta, or the abdominal aorta. The impeller rotates at speeds of 8,000 to 12,000 rpm providing blood flow of up to seven L/minute. At higher speeds the pump can produce 10 L/minute. Power is provided through an abdominal drive line.


Criteria:

Inclusion Criteria: (The following are general inclusion criteria; more specific criteria are outlined in the study protocol). - Transplant listed UNOS status IA or IB patients. - BSA >1.5 m2 and <2.3 m2. - Dependent on one or more intravenous inotropic agents or an intraaortic balloon pump (IABP). Exclusion Criteria:(The following are general exclusion criteria; more specific criteria are outlined in the study protocol). - Known risk factors or conditions that would contraindicate LVAD implantation or adversely affect patient survival. - Evidence of end organ dysfunction. - Known coagulopathy or contraindication of anticoagulation or antiplatelet agents. - Systemic infection. - Malignancies not in remission. - Current participation in investigational trials with other devices, drugs, or biologic agents.


NCT ID:

NCT00591799


Primary Contact:

Mary Blinder, M.D.
Phone: 212-397-3911 ext. 30
Email: mblinder@jarvikheart.com


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland 21201
United States

Bartley Griffith, MD
Phone: 410-328-3822
Email: bgriffith@smail.umaryland.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.